VIRTUS ADVISERS, LLC

Position in ROIV — Roivant Sciences Ltd.

CIK 1587281 HARTFORD, CT

Position in ROIV

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$637,267

+$198,222 QoQ

Shares Held

18,007

+13.6% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.30%

of 13F equity value

Holder Rank

#263

of 499 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

VIRTUS ADVISERS, LLC holds $9,774,150 across 19 Biotechnology names. ROIV ranks #7 (6.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACAD	Acadia Pharmaceuticals Inc	44,384	$1,122,914
2	HRMY	Harmony Biosciences Holdings, Inc.	29,253	$1,065,101
3	EXEL	Exelixis, Inc.	14,769	$803,581
4	ARWR	Arrowhead Pharmaceuticals, Inc.	9,249	$753,885
5	INVA	Innoviva, Inc.	30,614	$695,243
6	VCEL	Vericel Corp	15,570	$692,709
7	ROIV	Roivant Sciences Ltd. This page	18,007	$637,267
8	SRPT	Sarepta Therapeutics, Inc.	27,098	$486,950

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$637,267	18,007	+13.6%	Shares	Other	2026-08-11
2026-03-31	$439,045	15,850	-46.1%	Shares	Other	2026-05-14
2024-12-31	$348,180	29,432	-3.4%	Shares	Other	2025-02-14
2024-09-30	$351,589	30,467	0.0%	Shares	Other	2024-11-14
2024-06-30	$322,036	30,467	-11.0%	Shares	Other	2024-08-14
2024-03-31	$360,815	34,233	+16.8%	Shares	Other	2024-05-15
2023-12-31	$329,128	29,308	-6.5%	Shares	Other	2024-02-15
2023-09-30	$366,027	31,338	-11.4%	Shares	Other	2023-11-07
2023-06-30	$356,721	35,389	-17.0%	Shares	Other	2023-08-14
2023-03-31	$314,830	42,660	+1.8%	Shares	Other	2023-05-15
2022-12-31	$334,820	41,905	-33.5%	Shares	Other	2023-02-14
2022-09-30	$203,040	63,056	+1.5%	Shares	Other	2022-11-14
2022-06-30	$252,865	62,129	+235.0%	Shares	Other	2022-08-12
2022-03-31	$91,617	18,546	-5.6%	Shares	Other	2022-05-16
2021-12-31	$198,051	19,648	—	Shares	Other	2022-02-14
No filing history on record for this holder in this stock.